BSE filing, NSE: 360ONE. Summary written from the filing by ALFA Finder's alert engine.
360 One Wam Ltd: key numbers
- Share price
- ₹985.00
- Market cap
- ₹42,245 Cr
- Revenue (annual)
- ₹4,362 Cr
- Net profit (annual)
- ₹1,216 Cr
- P/E (TTM)
- 33.9×Sector 19.8×
- Promoter holding
- 5.88%-0.32% QoQ
- FII holding
- 56.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from 360 One Wam Ltd
All →360 One Wam Other Announcement
360 ONE WAM sold 1,200 equity shares worth Rs.12,26,292 on NSE on 23 October 2026 under a PIT disclosure. The seller is a Designated Person, and the holding fell to zero.
- Value
- ₹0.12 Cr
360 One Wam Employee Stock Options
360 ONE WAM LIMITED allotted 4,61,384 equity shares to employees following the exercise of stock options under its ESOP scheme.
360 One Wam Debt & Borrowing: ₹200 Cr
360 ONE WAM redeemed its ₹200 Crore Commercial Paper in full at maturity on 22 October 2026. The entire principal was repaid to investors.
- Value
- ₹200.0 Cr
360 One Wam Convertible Warrants
UBS AG warrants converted into 2.05 crore equity shares at Rs.1,030 each. Balance 75% exercise price of Rs.1,583.85 Crore received by 360 ONE WAM.
- Value
- ₹1,584 Cr
360 One Wam Convertible Warrants
360 ONE WAM allotted 2,05,02,939 shares to UBS AG on warrant conversion at Rs.1,030 each. Consideration: Rs.2,111.80 Crore, giving UBS ~4.8%.
- Value
- ₹2,112 Cr
360 One Wam Earnings Call Transcript: Key Takeaways
Q2 FY27 earnings call highlights solid AUM growth to ₹9 lakh Cr (up 31% YoY). PAT stood at ₹302 Cr.
Other regulatory approval announcements
All →AGI Infra Regulatory Approval
Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.
- Execution
- Valid up to March 30, 2031
Nesco Regulatory Approval
Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.
Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.